|

Cyclin-Dependent Kinase 4 Inhibitor Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CDK4 Inhibitor

Pipeline

Phase 2: 1

Top Sponsors

  • University of Washington1

Indications

  • Metastatic Hormone Receptor-Positive Breast Carcinoma1
  • Metastatic HER2 Negative Breast Carcinoma1
  • Anatomic Stage IV Breast Cancer AJCC v81
  • Breast Cancer1
  • Cancer1

Seattle, Washington1 trial

A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer

Fred Hutch/University of Washington Cancer Consortium

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.